Kyle Dennis – former broke college student – grew his account 15,971% in four years. Those returns beat every major hedge fund on the face of the Earth.
He buys biotech stocks right before they explode.
AND…
He does it in a way that strictly limits his risk.
Let me give you an example…
On August 7th MyoKardia inc (NASDAQ:MYOK) announced positive results in its Phase II trial for a new heart therapy. The stock popped.
Within 48 hours it had rocketed 113% — adding $790 million to its market cap.
If you were holding MYOK stock, you doubled your money.
But, you also took on a LOT of risk. If MyoKardia had flopped its Phase II trial – the stock would have cratered… costing you 80-90% of your investment.
Kyle has a 3-Step Strategy for avoiding that risk.
He used it to turn $15,253 into $2,855,475 in just four years.
Now Kyle is sharing the secrets behind his strategy in a special online training event.
If you’re lucky enough to attend – you’ll get a complete walkthrough of his strategy that’s taken him from broke college student to multi-millionaire.
In This Special Online Event You’ll Learn:
- The Basics of Trading Biotech Stocks
- The Secret to Kyle’s 18,912% Return
- 10 Reasons Why Biotech Can Be Lucrative
- Powerful ‘Catalyst’ Profit Strategies
- How to Find Upcoming Biotech Catalysts
- Step-by-Step Methods to WIN Your Valuation
- And so much more!
Just imagine how your life might change if you could pull $900-1,300 out of the market in a matter of days… all thanks to a “catalyst anomaly” very few know about.
This special situation only exists in biotechnology stocks.
You won’t hear about it from any of the mainstream trading “gurus.” But, for a limited time – Kyle is willing to reveal precisely how it works. Don’t miss out!
JOIN THIS SPECIAL ONLINE EVENT:
Learn the 3-Step Plan Kyle Used to
Turn $15,253 into $2,855,475